Single-use Filtration Assemblies Market (2026 - 2033) Size, Share & Trends Analysis Report By Type (Membrane Filtration, Depth Filtration, Centrifugation), By Product (Filters, Cartridges, Membranes, Manifold, Cassettes), By Application, By Region, And Segment Forecasts

Single-use Filtration Assemblies Market Summary

The global single-use filtration assemblies market size was valued at USD 4.3 billion in 2025 and is projected to reach USD 16.0 billion by 2033, growing at a CAGR of 18.4% from 2026 to 2033. Growth is driven by rising adoption of single-use technologies, increasing biologics production, and demand for cost-efficient, contamination-free filtration solutions.

Rising adoption of single-use technologies in bioprocessing

Rising adoption of single-use technologies in bioprocessing is a key driver of the single-use filtration assemblies market. Biopharmaceutical manufacturers are shifting from stainless-steel systems to disposable solutions to improve efficiency and reduce capital costs. These systems eliminate cleaning, sterilization, and validation steps, enabling faster turnaround times and minimizing downtime, especially in multi-product and clinical-scale manufacturing.

Technological Advancements in Single-Use Systems

Source: Secondary Research, Grand View Research

In addition, single-use technologies offer high flexibility and scalability, making them ideal for biologics and personalized therapies. The increasing use of these systems is driving demand for components such as filtration assemblies. Their ability to reduce contamination risk and lower water and energy usage further supports regulatory compliance and sustainability goals, driving wider adoption.

Focus on Sterility & Quality Assurance

Stringent regulatory requirements for sterile drug manufacturing are a key driver of demand in the single-use filtration assemblies market. Regulatory bodies such as the U.S. Food and Drug Administration and the European Medicines Agency enforce strict standards for aseptic processing and contamination control, increasing the need for reliable filtration solutions. Single-use filtration assemblies, being pre-sterilized and disposable, help reduce contamination risks and eliminate the need for complex cleaning and revalidation processes.

In addition, the growing focus on quality-by-design (QbD) and good manufacturing practices (GMP) is accelerating the adoption of single-use technologies. These systems offer improved traceability, consistent performance, and reduced human intervention, supporting regulatory compliance. As companies prioritize batch consistency and faster approvals, demand for ready-to-use filtration assemblies continues to increase.

Market Concentration & Characteristics

The degree of innovation in the single use filtration assemblies industry is high, driven by advancements in bioprocessing and the need for greater efficiency and sterility. Manufacturers are developing integrated, ready-to-use systems with improved membrane performance, gamma-sterilized components, and better aseptic connectivity. Increasing integration with automated and digital systems is further enhancing process control and flexibility, supporting the shift toward scalable and cost-effective single-use solutions.

The level of M&A activity is moderate to high, driven by the need to expand product portfolios and technological capabilities. Companies are engaging in acquisitions and partnerships to enhance manufacturing capacity and offer integrated bioprocessing solutions. This consolidation trend is expected to continue as competition and demand for advanced single-use technologies increase.

Regulations have a significant impact on the single use filtration assemblies industry, as stringent standards for sterility, safety, and product quality drive adoption. Authorities such as the U.S. Food and Drug Administration and the European Medicines Agency require strict compliance with aseptic processing and contamination control, encouraging the use of pre-sterilized, single-use systems. While these regulations support market growth by increasing demand for reliable filtration solutions, they also put pressure on manufacturers to meet validation, documentation, and material-compatibility requirements.

Product expansion in the single-use filtration assemblies industry is strong, with companies introducing advanced systems featuring improved performance and broader applications. There is increasing focus on customizable and process-specific assemblies to support biologics and advanced therapies, helping companies meet diverse needs and enhance competitiveness.

Regional expansion is significant, driven by the growing biopharmaceutical industry in emerging regions. Companies are expanding their presence in the Asia-Pacific and other developing markets to capitalize on increasing manufacturing activities and investments. This expansion helps improve market reach, strengthen supply chains, and support rising demand for cost-effective bioprocessing solutions.

Type Insights

In 2025, the membrane filtration segment led the single-use filtration assemblies market with a 47.8% share, driven by its widespread use in biopharmaceutical manufacturing for efficient removal of contaminants, microorganisms, and particulates. Its high filtration efficiency, compatibility with single-use systems, and critical role in ensuring product sterility and quality have significantly contributed to its dominant position.

Depth filtration is the fastest-growing segment, driven by its high dirt-holding capacity and effectiveness in clarifying cell culture fluids and removing large particulates. Its suitability for upstream and early downstream processing, along with increasing use in biologics production, is accelerating its adoption.

Product Insights

The filter segment led the market in 2025, accounting for a 21.0% share, and it is expected to grow at the fastest CAGR throughout the forecast period, driven by its critical role in ensuring sterility and product quality across biopharmaceutical processes. High demand for efficient contaminant removal, along with its widespread use in both upstream and downstream applications, has supported its dominant position.

The membranes segment is expected to grow at a significant rate over the forecast period, driven by increasing adoption in biopharmaceutical manufacturing, particularly in filtration, separation, and purification processes. Rising demand for single-use technologies and stringent regulatory requirements for product purity and contamination control are further accelerating its uptake across the industry.

Application Insights

The bioprocessing/biopharmaceuticals segment dominated the market with a revenue share of 43.1% in 2025, driven by the growing production of biologics, vaccines, and advanced therapies. The need for sterile, efficient, and scalable filtration solutions in both upstream and downstream processes has significantly supported segment growth.

Pharmaceutical manufacturing is expected to witness significant growth from 2026 to 2033, driven by increasing drug production volumes, rising demand for sterile processing, and the growing adoption of single-use technologies to enhance efficiency and reduce contamination risks. In addition, the shift toward flexible and cost-effective manufacturing systems is supporting greater integration of single-use filtration assemblies.

Regional Insights

North America single-use filtration assemblies industry dominated the global market and accounted for a 39.9% share in 2025, supported by a well-established biopharmaceutical industry, strong presence of key market players, and advanced manufacturing infrastructure. High adoption of single-use technologies, coupled with stringent regulatory standards for sterile processing, is driving demand.

U.S.Single-use Filtration Assemblies Market Trends

The single-use filtration assemblies industry in the U.S. is driven by large-scale biologics production and early adoption of advanced single-use systems, particularly in high-value therapies such as cell and gene treatments. Strong innovation ecosystems and continuous process optimization initiatives further strengthen demand.

Europe Single-use Filtration Assemblies Market Trends

The single-use filtration assemblies industry in Europe represents a significant market, driven by a robust pharmaceutical manufacturing base and increasing focus on quality and regulatory compliance. The region is witnessing growing adoption of single-use systems to enhance operational efficiency and meet strict sterility requirements. Expansion of contract manufacturing organizations and rising biologics production are further supporting demand.

The UK single-use filtration assemblies industry benefits from a dynamic research environment, where collaboration between academia and industry is accelerating the uptake of flexible and scalable bioprocessing solutions.

The single-use filtration assemblies industry in Germany is supported by precision-driven manufacturing and a strong emphasis on engineering efficiency. Companies are increasingly integrating single-use filtration to streamline operations and enhance production reliability.

Asia Pacific Single-use Filtration Assemblies Market Trends

The single-use filtration assemblies industry in the Asia Pacific is anticipated to witness the fastest growth at a CAGR of 20.9% from 2026 to 2033, fueled by expanding biopharmaceutical manufacturing, increasing investments in healthcare infrastructure, and growing outsourcing activities. Countries such as China and India are emerging as key hubs due to cost advantages and supportive government initiatives. The rising demand for affordable biologics and vaccines is accelerating the adoption of single-use filtration assemblies.

The China single-use filtration assemblies industry is witnessing rapid industrial expansion and increasing domestic demand for biologics, driving large-scale deployment of cost-efficient single-use filtration technologies across new manufacturing facilities.

The single-use filtration assemblies industry in Japan is characterized by a focus on process refinement and space-efficient manufacturing. The adoption of compact, single-use systems aligns with the country’s need for high-quality output within constrained production environments.

Middle East and Africa Single-use Filtration Assemblies Market Trends

The single-use filtration assemblies industry in the Middle East & Africa is witnessing gradual growth, driven by increasing investments in healthcare infrastructure and the expansion of pharmaceutical manufacturing capabilities. Countries such as Saudi Arabia and the United Arab Emirates are focusing on local drug production and reducing import dependency, supporting the adoption of single-use technologies.

The Kuwait single-use filtration assemblies industry is gradually advancing through strategic healthcare investments, with a focus on building localized pharmaceutical capabilities and adopting modern, low-infrastructure bioprocessing solutions.

Key Single-use Filtration Assemblies Company Insights

The single-use filtration assemblies market is moderately consolidated, led by major players such as Sartorius AG, Merck Millipore, Danaher Corporation, and Thermo Fisher Scientific. These companies dominate due to strong product portfolios, global reach, and continuous innovation in bioprocessing solutions, supported by R&D investments and acquisitions.

Mid-sized and niche players like Repligen Corporation, MEISSNER FILTRATION PRODUCTS, INC., and 3M Purification compete through specialized technologies and customized single-use filtration systems. Smaller companies such as DrM, Cellab, and Medela focus on application-specific solutions, while overall competition is driven by innovation, partnerships, and expansion into emerging biopharma markets.

Recent Developments

• In February 2026, in the U.S., AdvantaPure launched EcoFlex sustainable TPE tubing with regional distributor Carolina Components Group, expanding single-use filtration assemblies applications by offering lower-carbon, weldable components for biopharmaceutical manufacturing and regulated single-use systems.

• In October 2025, in the U.S., Avantor introduced next-generation sterile sampling platforms and pre-engineered PUPSIT assemblies aligned with the single-use filtration assemblies industry, enhancing contamination control, process efficiency, and integration in single-use bioprocessing systems.

Single-use Filtration Assemblies Market Report Scope

Global Single-use Filtration Assemblies Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global single-use filtration assemblies market report on the basis of type, application, product, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Membrane Filtration

    • Tangential Flow Filtration (TFF)

      • Ultra/Diafiltration

      • Micro-Filtration

    • Direct Flow Filtration (DFF) /Dead-end Filtration /Normal Flow Filtration

  • Depth Filtration

  • Centrifugation

  • Others

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceuticals Manufacturing

  • Bioprocessing/Biopharmaceuticals

  • Laboratory Use

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Filters

  • Cartridges

  • Membranes

  • Manifold

  • Cassettes

  • Syringes

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait